{"id":402544,"date":"2020-12-18T02:03:06","date_gmt":"2020-12-18T07:03:06","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=402544"},"modified":"2020-12-18T02:03:06","modified_gmt":"2020-12-18T07:03:06","slug":"lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/","title":{"rendered":"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene<\/b><\/p>\n<p>PARIS&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nRegulatory News:\n<\/p>\n<p>\nLysogene (Paris:LYS) (FR0013233475 \u2013 LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces a change in the governance and control of KGA, a company co-owned by Karen Aiach and which currently owns approximately 6% of Lysogene&#8217;s capital.\n<\/p>\n<p>\nAs part of a reorganization of her personal assets, Karen Aiach, founder and Chief Executive Officer of Lysogene, has resigned from her position as Chairman of KGA and sold some of her shares in KGA, which she consequently no longer jointly controls.\n<\/p>\n<p>\nThese changes are in response to personal considerations, not specific to the stake held in Lysogene. Moreover, they have no impact on the interest that Karen Aiach holds directly in the capital of Lysogene.\n<\/p>\n<p>\nKaren Aiach confirms that KGA will continue to support Lysogene. She also reaffirms her determination to exercise her functions within the company and to remain fully focused on her missions within Lysogene.\n<\/p>\n<p><b>About Lysogene<br \/>\n<br \/><\/b>Lysogene is a gene therapy Company focused on the treatment of orphan diseases of the central nervous system (CNS). The Company has built a unique capability to enable a safe and effective delivery of gene therapies to the CNS to treat lysosomal diseases and other genetic disorders of the CNS. A phase 2\/3 clinical trial in MPS IIIA in partnership with Sarepta Therapeutics, Inc. is ongoing and a phase 1\/3 clinical trial in GM1 gangliosidosis is in preparation. In accordance with the agreements signed between Lysogene and Sarepta Therapeutics, Inc., Sarepta Therapeutics, Inc. will hold exclusive commercial rights to LYS-SAF302 in the United States and markets outside Europe; and Lysogene will maintain commercial exclusivity of LYS-SAF302 in Europe. Lysogene is also collaborating with an academic partner to define the strategy of development for the treatment of Fragile X syndrome, a genetic disease related to autism. <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.lysogene.com&amp;esheet=52350697&amp;newsitemid=20201217005909&amp;lan=en-US&amp;anchor=www.lysogene.com&amp;index=1&amp;md5=b272555b0430d854d47cd5e87da67784\">www.lysogene.com<\/a>.\n<\/p>\n<p><b>Forward Looking Statement<br \/>\n<br \/><\/b>This press release may contain certain forward-looking statements, especially on the Company\u2019s progress of its phase 2-3 clinical trial and cash runway. Although the Company believes its expectations are based on reasonable assumptions, all statements other than statements of historical fact included in this press release about future events are subject to (i) change without notice, (ii) factors beyond the Company\u2019s control, (iii) clinical trial results, (iv) increased manufacturing costs and (v) potential claims on its products. These statements may include, without limitation, any statements preceded by, followed by or including words such as \u201ctarget,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201caim,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201canticipate,\u201d \u201cestimate,\u201d \u201cplan,\u201d \u201cobjective\u201d, \u201cproject,\u201d \u201cwill,\u201d \u201ccan have,\u201d \u201clikely,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201ccould\u201d and other words and terms of similar meaning or the negative thereof. Forward-looking statements are subject to inherent risks and uncertainties beyond the Company\u2019s control that could cause the Company\u2019s actual results, performance or achievements to be materially different from the expected results, performance or achievements expressed or implied by such forward-looking statements. A further list and description of these risks, uncertainties and other risks can be found in the Company\u2019s regulatory filings with the French Autorit\u00e9 des March\u00e9s Financiers, including in the 2019 universal registration document, registered with the French Markets Authorities on April 30, 2020, under number D.20-0427, and future filings and reports by the Company. Furthermore, these forward-looking statements are only as of the date of this press release. Readers are cautioned not to place undue reliance on these forward-looking statements. Except as required by law, the Company assumes no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. If the Company updates one or more forward-looking statements, no inference should be drawn that it will or will not make additional updates with respect to those or other forward-looking statements.\n<\/p>\n<p>\nThis press release has been prepared in both French and English. In the event of any differences between the two texts, the French language version shall supersede.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201217005909r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201217005909\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201217005909\/en\/<\/a><\/span><\/p>\n<p>\nSt\u00e9phane Durant des Aulnois<br \/>\n<br \/>Chief Financial Officer<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:stephane.durant-des-aulnois@lysogene.com\">stephane.durant-des-aulnois@lysogene.com<br \/>\n<\/a><br \/>+ 33 1 41 43 03 99\n<\/p>\n<p><b>KEYWORDS:<\/b> Europe United States North America France<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Infectious Diseases Stem Cells Genetics Other Health Clinical Trials<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene PARIS&#8211;(BUSINESS WIRE)&#8211; Regulatory News: Lysogene (Paris:LYS) (FR0013233475 \u2013 LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces a change in the governance and control of KGA, a company co-owned by Karen Aiach and which currently owns approximately 6% of Lysogene&#8217;s capital. As part of a reorganization of her personal assets, Karen Aiach, founder and Chief Executive Officer of Lysogene, has resigned from her position as Chairman of KGA and sold some of her shares in KGA, which she consequently no longer jointly controls. These changes are in response to personal considerations, not specific to the stake held in Lysogene. Moreover, they &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-402544","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene PARIS&#8211;(BUSINESS WIRE)&#8211; Regulatory News: Lysogene (Paris:LYS) (FR0013233475 \u2013 LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces a change in the governance and control of KGA, a company co-owned by Karen Aiach and which currently owns approximately 6% of Lysogene&#8217;s capital. As part of a reorganization of her personal assets, Karen Aiach, founder and Chief Executive Officer of Lysogene, has resigned from her position as Chairman of KGA and sold some of her shares in KGA, which she consequently no longer jointly controls. These changes are in response to personal considerations, not specific to the stake held in Lysogene. Moreover, they &hellip; Continue reading &quot;Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-18T07:03:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201217005909r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene\",\"datePublished\":\"2020-12-18T07:03:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/\"},\"wordCount\":727,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201217005909r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/\",\"name\":\"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201217005909r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-12-18T07:03:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201217005909r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201217005909r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/","og_locale":"en_US","og_type":"article","og_title":"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene - Market Newsdesk","og_description":"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene PARIS&#8211;(BUSINESS WIRE)&#8211; Regulatory News: Lysogene (Paris:LYS) (FR0013233475 \u2013 LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces a change in the governance and control of KGA, a company co-owned by Karen Aiach and which currently owns approximately 6% of Lysogene&#8217;s capital. As part of a reorganization of her personal assets, Karen Aiach, founder and Chief Executive Officer of Lysogene, has resigned from her position as Chairman of KGA and sold some of her shares in KGA, which she consequently no longer jointly controls. These changes are in response to personal considerations, not specific to the stake held in Lysogene. Moreover, they &hellip; Continue reading \"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-18T07:03:06+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201217005909r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene","datePublished":"2020-12-18T07:03:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/"},"wordCount":727,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201217005909r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/","name":"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201217005909r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-12-18T07:03:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201217005909r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201217005909r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lysogene-announces-a-change-in-the-organization-of-kga-minority-shareholder-of-lysogene\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/402544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=402544"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/402544\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=402544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=402544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=402544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}